Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Heart failure with mid‐range ejection fraction: pro and cons of the new classification of Heart Failure by European Society of Cardiology guidelines
Luca Branca, Marco Sbolli, Marco Metra, et al.
ESC Heart Failure (2020) Vol. 7, Iss. 2, pp. 381-399
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Impact of comorbid constipation on the survival of patients with heart failure: a multicenter, prospective cohort study conducted in Japan
Tomoaki Ishida, Kei Kawada, Kohei Jobu, et al.
Frontiers in Cardiovascular Medicine (2025) Vol. 11
Open Access
Characterizing High Risk Patients in Heart Failure
Frederique J. Hafkamp, Henk L. Dekker, R.A. Tio, et al.
The Journal of Cardiovascular Nursing (2025)
Closed Access
Prevalence and Prognostic Implication of Atrial Fibrillation in Heart Failure Subtypes: Systematic Review and Meta-Analysis
Juan Mundisugih, Kyle B. Franke, Phillip J. Tully, et al.
Heart Lung and Circulation (2023) Vol. 32, Iss. 6, pp. 666-677
Open Access | Times Cited: 12
Sacubitril/valsartan inhibits obesity-associated diastolic dysfunction through suppression of ventricular-vascular stiffness
Annayya R. Aroor, Srinivas Mummidi, Juan Carlos López-Alvarenga, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 24
Ischemic Stroke and Heart Failure: Facts and Numbers. An Update
Anush Barkhudaryan, Wolfram Doehner, Nadja Scherbakov
Journal of Clinical Medicine (2021) Vol. 10, Iss. 5, pp. 1146-1146
Open Access | Times Cited: 21
Plasma microrna expression profile for reduced ejection fraction in dilated cardiomyopathy
María Calderón‐Domínguez, Thalía Belmonte, Maribel Quezada-Feijoó, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 18
Does the Measurement of Ejection Fraction Still Make Sense in the HFpEF Framework? What Recent Trials Suggest
Alberto Palazzuoli, Michele Correale, Massimo Iacoviello, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 2, pp. 693-693
Open Access | Times Cited: 7
Prognostic Value of Epicardial Adipose Tissue in Heart Failure With Mid‐Range and Preserved Ejection Fraction: A Multicenter Study
Wenxian Wang, Yan Gao, Jian Wang, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 24
Open Access | Times Cited: 2
Heart Failure With Mid-range Ejection Fraction: A Distinctive Subtype or a Transitional Stage?
Qing Zhou, Peixin Li, Hengli Zhao, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 17
Cardiac reverse remodelling and health status in patients with chronic heart failure
Kaiming Wang, Erik Youngson, Jeffrey A. Bakal, et al.
ESC Heart Failure (2021) Vol. 8, Iss. 4, pp. 3106-3118
Open Access | Times Cited: 15
Heart failure with mildly reduced ejection fraction: from diagnosis to treatment. Gaps and dilemmas in current clinical practice
Marta Cvijić, Yelena Rib, Suzana Danojevic, et al.
Heart Failure Reviews (2022) Vol. 28, Iss. 4, pp. 767-780
Closed Access | Times Cited: 9
Prognostic Role of the Left Ventricular Global Function Index in Predicting Major Adverse Cardiovascular Events in Acute Coronary Syndrome Patients
Birsen Doğanay, Özlem Özcan Çelebi
Biomarkers in Medicine (2023) Vol. 17, Iss. 1, pp. 5-16
Closed Access | Times Cited: 5
Assessment of prevalence and monitoring of outcomes in patients with heart failure in Russia
Е. V. Shlyakhto, Н. Э. Звартау, S. Villevalde, et al.
Russian Journal of Cardiology (2020) Vol. 25, Iss. 12, pp. 4204-4204
Open Access | Times Cited: 14
The obesity paradox in heart failure: What is the role of cardiorespiratory fitness?
Asaduzzaman Khan, Erik H. Van Iterson, Luke J. Laffin
Cleveland Clinic Journal of Medicine (2021) Vol. 88, Iss. 8, pp. 449-458
Open Access | Times Cited: 12
AT1 receptor blocker, but not an ACE inhibitor, prevents kidneys from hypoperfusion during congestive heart failure in normotensive and hypertensive rats
Vojtěch Krátký, Zdenka Vaňourková, Matúš Sýkora, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 11
Are HFpEF and HFmrEF So Different? The Need to Understand Distinct Phenotypes
Alberto Palazzuoli, Matteo Beltrami
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 11
Heart Failure With Midrange Ejection Fraction—What Is It, If Anything?
Jacinthe Boulet, Emmanuelle Massie, Jean‐Lucien Rouleau
Canadian Journal of Cardiology (2020) Vol. 37, Iss. 4, pp. 585-594
Closed Access | Times Cited: 8
Association of the medical therapy with beta-blockers or inhibitors of renin-angiotensin system with clinical outcomes in patients with mildly reduced left ventricular ejection fraction after acute myocardial infarction
Seung‐Jae Joo, Song‐Yi Kim, Jae-Geun Lee, et al.
Medicine (2022) Vol. 101, Iss. 42, pp. e30846-e30846
Open Access | Times Cited: 4
Development of algorithms for determining heart failure with reduced and preserved ejection fraction using nationwide electronic healthcare records in the UK
Varun Sundaram, Rosita Zakeri, Klaus K. Witte, et al.
Open Heart (2022) Vol. 9, Iss. 2, pp. e002142-e002142
Open Access | Times Cited: 4
Heart failure with mildly reduced ejection fraction: emerging frontiers in clinical characteristics, prognosis, and treatment
Zhi Shang, Xinyu Wang, Wei Dong Gao
Reviews in Cardiovascular Medicine (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Heart failure with preserved ejection fraction: key stumbling blocks for experimental drugs in clinical trials
Amanda Lloji, Jayakumar Sreenivasan, Joel Novograd, et al.
Expert Opinion on Investigational Drugs (2022) Vol. 31, Iss. 5, pp. 463-474
Closed Access | Times Cited: 3
Cardiac medication management in Duchenne muscular dystrophy
Samuel G. Wittekind, Chet Villa
Pediatric Pulmonology (2021) Vol. 56, Iss. 4, pp. 747-752
Closed Access | Times Cited: 4
Extra‐cardiac targets in the management of cardiometabolic disease: Device‐based therapies
Ana Jorbenadze, Marat Fudim, Felix Mahfoud, et al.
ESC Heart Failure (2021) Vol. 8, Iss. 4, pp. 3327-3338
Open Access | Times Cited: 4
Evaluation of Left Heart Function in Heart Failure Patients with different types of Ejection Fraction using Transthoracic Three-Dimensional Echocardiography Heart-Model
Shen-Yi Li, Yi Zhang, Qingqing Long, et al.
Research Square (Research Square) (2024)
Open Access
Page 1 - Next Page

Scroll to top